{"id":74417,"date":"2022-05-18T13:07:21","date_gmt":"2022-05-18T11:07:21","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/"},"modified":"2025-10-13T15:27:54","modified_gmt":"2025-10-13T13:27:54","slug":"la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/","title":{"rendered":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech"},"content":{"rendered":"<p><strong>La biotecnol\u00f3gica norteamericana <a href=\"https:\/\/www.verisimlife.com\/\" target=\"_blank\" rel=\"noopener\">VeriSIM Life<\/a>\u00a0-un referente global en plataformas computacionales de \u00faltima generaci\u00f3n para el desarrollo de f\u00e1rmacos- ha adquirido la startup\u00a0 <a href=\"https:\/\/www.molomics.com\/\" target=\"_blank\" rel=\"noopener\">Molomics Biotech<\/a>, propietaria de una tecnolog\u00eda &#8216;deep tech&#8217; patentada que combina la inteligencia colectiva humana con la artificial para el dise\u00f1o de nuevas mol\u00e9culas terap\u00e9uticas. Se trata del \u00faltimo caso de \u00e9xito de un proyecto emprendedor gestado en el ecosistema del Parque Cient\u00edfico de Barcelona.<\/strong><\/p>\n<p>Creada en 2015 por Jascha Blobel (CEO), Giovanni Cincilla (CSO) y Simone Masoni, (CTO), la mayor\u00eda de su capital estaba en manos del equipo fundador, lo que ha garantizado una ejecuci\u00f3n \u00e1gil de su plan de negocio y la maximizaci\u00f3n del beneficio para sus inversores.<\/p>\n<p>En virtud de la transacci\u00f3n, cuyo importe no ha trascendido, la gran mayor\u00eda de accionistas recibir\u00e1n tambi\u00e9n participaciones en VeriSIM Life, que levant\u00f3 $15 millones (unos 14,4 millones de euros) en una ronda Series A en enero de este a\u00f1o.<\/p>\n<p>Desde su sede en el Parque Cient\u00edfico de Barcelona, Molomics culmin\u00f3 el desarrollo de una <a href=\"https:\/\/www.molomics.com\/#technology\">tecnolog\u00eda patentada<\/a>, cuya innovaci\u00f3n radica en que integra la inteligencia colectiva humana con la inteligencia artificial para determinar en tiempo real nuevas estructuras qu\u00edmicas con alta actividad terap\u00e9utica y propiedades farmacol\u00f3gicas superiores a los medicamentos actualmente desarrollados o comercializados. Esta combinaci\u00f3n de m\u00e9todos de aprendizaje autom\u00e1tico (machine learning) y el conocimiento de especialistas en este campo permite reducir el n\u00famero de mol\u00e9culas que se ensayan in\u00fatilmente, lo cual puede representar un ahorro de cientos de millones de euros para la industria farmac\u00e9utica.<\/p>\n<p>Molomics ha utilizado este enfoque para avanzar un tratamiento para la enfermedad de Parkinson que aborda la discinesia\u00a0inducida por levodopa, un trastorno del movimiento asociado a esta patolog\u00eda y que puede provocar una importante\u00a0discapacidad f\u00edsica en los afectados.<\/p>\n<p>La tecnolog\u00eda de Molomics complementa la plataforma de inteligencia artificial <a href=\"https:\/\/www.verisimlife.com\/our-platform\/\">BIOiSIM\u2122<\/a> de VeriSIM<\/p>\n<p>para mejorar a\u00fan m\u00e1s las tasas de \u00e9xito en el descubrimiento, desarrollo y aprobaci\u00f3n de nuevos f\u00e1rmacos para las enfermedades m\u00e1s desafiantes que afectan a la humanidad. La combinaci\u00f3n de ambas herramientas computacionales de \u00faltima generaci\u00f3n permitir\u00e1 a los investigadores realizar una verificaci\u00f3n previa de nuevos f\u00e1rmacos en menos tiempo y con costes reducidos, aumentando as\u00ed la tasa de \u00e9xito en el desarrollo cl\u00ednico.<\/p>\n<p>\u201cEsta adquisici\u00f3n representa un paso considerable en nuestra estrategia para acelerar un crecimiento a largo plazo y complementar nuestra plataforma inform\u00e1tica patentada para desarrollar terapias efectivas con mayor rapidez y precisi\u00f3n que los m\u00e9todos tradicionales\u201d, explica la <strong>Dra. Jo Varshney<\/strong>, fundadora y directora ejecutiva de VeriSIM Life. \u201cJunto con los avances en la investigaci\u00f3n de la enfermedad de Parkinson, planeamos cubrir el espectro completo del dise\u00f1o y desarrollo de f\u00e1rmacos para el tratamiento de enfermedades neurol\u00f3gicas, oncol\u00f3gicas y otras que amenazan la vida\u201d.<\/p>\n<p>\u201cEstamos encantados de unirnos al equipo de VeriSIM Life e incrementar la capacidad de una plataforma de predicci\u00f3n traslacional, ya poderosa con nuestra tecnolog\u00eda \u00fanica y altamente complementaria\u201d, afirma el <strong>Dr. Jascha Blobel,<\/strong> CEO de Molomics. \u201cNuestra colaboraci\u00f3n ha logrado resultados iniciales prometedores, y creemos que lo mejor est\u00e1 por llegar\u201d.<\/p>\n<p>Desde su creaci\u00f3n, Molomics ha levantado m\u00e1s de 1 mill\u00f3n de euros de capital p\u00fablico y privado. Adem\u00e1s de recibir, desde sus inicios, el apoyo financiero del Ministerio de Ciencia e Innovaci\u00f3n -a trav\u00e9s del Programa Torres Quevedo- tambi\u00e9n ha contado con el respaldo de la <a href=\"https:\/\/www.michaeljfox.org\/\" target=\"_blank\" rel=\"noopener\">Michael J. Fox Foundation<\/a> en sus proyectos dirigidos a la enfermedad de Parkinson.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La biotecnol\u00f3gica norteamericana VeriSIM Life\u00a0-un referente global en plataformas computacionales de \u00faltima generaci\u00f3n para el desarrollo de f\u00e1rmacos- ha adquirido la startup\u00a0 Molomics Biotech, propietaria de una tecnolog\u00eda &#8216;deep tech&#8217;&#8230;<\/p>\n","protected":false},"author":4,"featured_media":74412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-74417","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La biotecnol\u00f3gica norteamericana VeriSIM Life\u00a0-un referente global en plataformas computacionales de \u00faltima generaci\u00f3n para el desarrollo de f\u00e1rmacos- ha adquirido la startup\u00a0 Molomics Biotech, propietaria de una tecnolog\u00eda &#8216;deep tech&#8217;...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T11:07:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:27:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Azucena Berea\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Azucena Berea\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/\"},\"author\":{\"name\":\"Azucena Berea\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"headline\":\"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech\",\"datePublished\":\"2022-05-18T11:07:21+00:00\",\"dateModified\":\"2025-10-13T13:27:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/\"},\"wordCount\":630,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Jascha-Blobel_Molomics-1.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/\",\"name\":\"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Jascha-Blobel_Molomics-1.jpg\",\"datePublished\":\"2022-05-18T11:07:21+00:00\",\"dateModified\":\"2025-10-13T13:27:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Jascha-Blobel_Molomics-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Jascha-Blobel_Molomics-1.jpg\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/810a86a39effe6bf90f9ab918ca43239\",\"name\":\"Azucena Berea\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g\",\"caption\":\"Azucena Berea\"},\"sameAs\":[\"https:\\\/\\\/www.pcb.ub.edu\"],\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/aberea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/","og_locale":"es_ES","og_type":"article","og_title":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona","og_description":"La biotecnol\u00f3gica norteamericana VeriSIM Life\u00a0-un referente global en plataformas computacionales de \u00faltima generaci\u00f3n para el desarrollo de f\u00e1rmacos- ha adquirido la startup\u00a0 Molomics Biotech, propietaria de una tecnolog\u00eda &#8216;deep tech&#8217;...","og_url":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2022-05-18T11:07:21+00:00","article_modified_time":"2025-10-13T13:27:54+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg","type":"image\/jpeg"}],"author":"Azucena Berea","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Azucena Berea","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/"},"author":{"name":"Azucena Berea","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"headline":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech","datePublished":"2022-05-18T11:07:21+00:00","dateModified":"2025-10-13T13:27:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/"},"wordCount":630,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/","url":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/","name":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg","datePublished":"2022-05-18T11:07:21+00:00","dateModified":"2025-10-13T13:27:54+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2022\/05\/Jascha-Blobel_Molomics-1.jpg","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/la-biotecnologica-norteamericana-verisim-life-adquiere-la-startup-molomics-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"La biotecnol\u00f3gica norteamericana VeriSIM Life adquiere la startup Molomics Biotech"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/810a86a39effe6bf90f9ab918ca43239","name":"Azucena Berea","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32577545a82a87a5c7e06fb02f02362edb2f379afdb4c8b5783d81635141181f?s=96&d=mm&r=g","caption":"Azucena Berea"},"sameAs":["https:\/\/www.pcb.ub.edu"],"url":"https:\/\/www.pcb.ub.edu\/es\/author\/aberea\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/74417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=74417"}],"version-history":[{"count":4,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/74417\/revisions"}],"predecessor-version":[{"id":74425,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/74417\/revisions\/74425"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/74412"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=74417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=74417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=74417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}